- Home
- DXST vs ASBP Comparison
DXST vs ASBP Comparison
Compare DXST & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXST
- ASBP
- Stock Information
- Founded
- DXST 2011
- ASBP 2021
- Country
- DXST China
- ASBP United States
- Employees
- DXST N/A
- ASBP N/A
- Industry
- DXST
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- DXST
- ASBP Health Care
- Exchange
- DXST NYSE
- ASBP Nasdaq
- Market Cap
- DXST 18.7M
- ASBP 17.6M
- IPO Year
- DXST 2025
- ASBP N/A
- Fundamental
- Price
- DXST $1.16
- ASBP $0.24
- Analyst Decision
- DXST
- ASBP
- Analyst Count
- DXST 0
- ASBP 0
- Target Price
- DXST N/A
- ASBP N/A
- AVG Volume (30 Days)
- DXST 36.5K
- ASBP 363.3K
- Earning Date
- DXST 01-01-0001
- ASBP 05-24-2025
- Dividend Yield
- DXST N/A
- ASBP N/A
- EPS Growth
- DXST 13.11
- ASBP N/A
- EPS
- DXST 0.14
- ASBP N/A
- Revenue
- DXST $11,542,292.00
- ASBP N/A
- Revenue This Year
- DXST N/A
- ASBP N/A
- Revenue Next Year
- DXST N/A
- ASBP N/A
- P/E Ratio
- DXST $8.91
- ASBP N/A
- Revenue Growth
- DXST 22.18
- ASBP N/A
- 52 Week Low
- DXST $0.85
- ASBP $0.32
- 52 Week High
- DXST $5.74
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- DXST N/A
- ASBP N/A
- Support Level
- DXST N/A
- ASBP N/A
- Resistance Level
- DXST N/A
- ASBP N/A
- Average True Range (ATR)
- DXST 0.00
- ASBP 0.00
- MACD
- DXST 0.00
- ASBP 0.00
- Stochastic Oscillator
- DXST 0.00
- ASBP 0.00
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.